See All Slides - tctmd.com

Slides

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Presenter: Ziyad M. Hijazi, John F. Rhodes, Carlos Pedra, Matthew J. Gillespie

September 14, 2014

Presentation TCT 2014

Early Technology Value Assessment: Market Opportunity Versus Development Risk

Presenter: Chaim S. Lotan, Paul G. Yock, Louis A. Cannon, Jay Watkins

September 14, 2014

Presentation TCT 2014

Understanding the Hemodynamics of Heart Failure

Presenter: Russell A. Brandwein, Michael Guiry, Kenneth A. Gorski

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Implications of the CTSN Trial on Transcatheter Mitral Valve Repair vs Replacement

Presenter: Steven F. Bolling, A. Pieter Kappetein, Neil E. Moat, Ted E. Feldman

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2014

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ronald M. Lazar

September 14, 2014

Advertisement

Slides

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

The BEST and BASIL 2 Studies: Designs and Goals

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Early Technology Value Assessment: Market Opportunity Versus Development Risk

Understanding the Hemodynamics of Heart Failure

The Data Strongly Support Bivalirudin!

Implications of the CTSN Trial on Transcatheter Mitral Valve Repair vs Replacement

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content